A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab With Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
- Chang, Jenny C. (Key Personnel)
- Darcourt, Jorge (Key Personnel)
- Geyer, Charles E. (Key Personnel)
- Niravath, Polly A. (Key Personnel)
Project: Clinical Trial